| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
3e-05 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
5e-05 |
| mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
6e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
9e-05 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |